3[1]McMillan R.Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol,2000,37:239
4[2]Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci,1998,19:237
5[3]Mcfarl J. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev, 2002.16
6[4]Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev,2002,16:9
7[5]Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood,1996,87:4245
8[6]Gernsheimer T. Pathophysiology and thrombokinetics in autoimmune thrombocytopenia. Blood Rev,2002,16:7
9[7]Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. Semin Hematol,2000,37:249
10[8]George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood,1996,88:3
2Devreese KM ,Van HF. Anticardiolipin and anti-beta2 glycoprotein- I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles,even for new auto- mated assays [J]. Thromb Res ,2011,128(6):598-600.
3Zar T,Kaplan AA. Predictable removal of antieardiolipin antibody by therapeutic plasma exchange(TPE)in catastrophic antiphospholipid anti- body syndrome(CAPS)[J]. Clin Nephro1,2008,70( 1 ):77-81.
4Aoki K,Dudkiewicz AB,Matsuura E,et al. Clinical significance of beta 2-glycoprotein I -dependent anticardiolipin antibodies in the repro- ductive autoimmune failure syndrome:correlation with conventional an- tiphospholipid antibody detection systems ~ Am J Obstet Gynecol, 1995,172 (3) :926-931.
5Guglielmone HA,Fernandez EJ. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome [J]. J Rheumatol, 1999,26 ( 1 ) : 86-90.
6Huang WN,Tso TK,Huang HY. Enhanced oxidative status but not cor- responding elevated antioxidative status by antieardiolipin antibody and disease activity in patients with systemic lupus erythematosus [J]. Rheumatol Int ,2007,27(5) :453-458.
7Ruiz IG,Cuadrado MJ,Ruiz Al,et al. Evidence-based recommendatlons for the prevention and long-term management of thrombosis in antiphos- pholipid antibody-positive patients:report of a task force at the 13th International Congress on antiphospholipid antibodies [J]. Lupus,2011,20 (2) :206-218.
8Turiel M ,Sarzi PP,Peretti R,et al. Five-year follow-up by trans- esophageal echocardiographic studies in primary antiphospholipid syn- drome [J]. Am J Cardiol,2005,96(4):574-579.
10Ahmed E, Stegmayr B ,Trifunovic J ,et al. Anticardiolipin antibodies are not an independent risk factor for stroke:an incident case-referent study nested within the MONICA and Vasterbotten cohort project [J]. Stroke, 2000,31 (6) : 1289-1293.
